Biotech News

Mangoceuticals Partners with T7X to Become the First Nasdaq-Listed Company to Offer Tokenized Preferred Stock on the T7X Platform

MANGOCEUTICALS (MGRX)MANGOCEUTICALSCompany update

Series D Preferred Stock to be offered at $10.00 per share through the issuance of tokens and issued natively on-chain, with T7X Equities serving as transfer agent; no common stock will be issued at closing

Related news

MANGOCEUTICALS

Men's Health and Wellness Company Mangoceuticals operates a telehealth platform offering prescription and wellness products for men. The business combines online medical consultations, pharmacy fulfillment, branded formulations, and direct-to-consumer marketing. Erectile Dysfunction Products The company's original Mango line includes...

Recent company news

Stock data

Close
0.13 USD
Market cap
6.58M USD
Exchange
NASDAQ
Sector
Biopharma
Location
United States